SBTX — Skinbiotherapeutics Share News

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapSucker Stock

Market Cap
£42.05m
Enterprise Value
£41.84m
Revenue
£1.21m

REG - SkinBioTherapeutics - Update regarding Nominated Adviser and Broker
22/11/2023 07:15Announcement
REG - SkinBioTherapeutics - Result of Retail Offer
21/11/2023 07:00Announcement
REG - SkinBioTherapeutics - Result of Placing
17/11/2023 07:00Announcement
REG - SkinBioTherapeutics - Placing and Retail Offer
16/11/2023 16:45Announcement
REG - SkinBioTherapeutics - Retail Offer
16/11/2023 16:45Announcement
REG - SkinBioTherapeutics - Acne study, Trading and Auditor updates
25/10/2023 07:30Announcement
REG - SkinBioTherapeutics - Extension of Croda contract for SkinBiotix™
19/10/2023 07:00Announcement
REG - SkinBioTherapeutics - health authority approval for AxisBiotix in France
15/09/2023 09:00Announcement
REG - SkinBioTherapeutics - Update on acne programme
05/09/2023 07:00Announcement
REG - SkinBioTherapeutics OptiBiotix Health - Holding(s) in Company
31/07/2023 13:00Announcement
REG - SkinBioTherapeutics - Regulatory Approval
21/06/2023 07:00Announcement
REG - SkinBioTherapeutics - Business progress update
14/06/2023 17:00Announcement
REG - SkinBioTherapeutics - SkinBiotix and AxisBiotix Update
10/05/2023 07:00Announcement
REG - SkinBioTherapeutics - Director/PDMR Shareholding
14/04/2023 07:00Announcement
REG - SkinBioTherapeutics - Half-year Report
28/03/2023 07:00Announcement
REG - SkinBioTherapeutics - Price Monitoring Extension
27/03/2023 16:45Announcement
REG - SkinBioTherapeutics - Director/PDMR Shareholding
09/03/2023 17:30Announcement
REG - SkinBioTherapeutics - Director/PDMR Shareholding
09/03/2023 17:30Announcement
REG - SkinBioTherapeutics - AxisBiotix-Ps™ approved for launch in Europe
07/03/2023 07:00Announcement
REG - SkinBioTherapeutics - Holding(s) in Company
20/02/2023 11:30Announcement